Sanofi: Information concerning the total number of voting rights and shares – September 2026

By GlobeNewswire

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)

Sanofi
a French société anonyme with a registered share capital of €2,415,546,786
Registered office : 46, avenue de la Grande Armée - 75017 Paris - France
Registered at the Paris Commercial and Companies Registry under number 395 030 844

Date
Total number of
issued shares
Number of real
voting rights
(excluding treasury shares)		Theoretical number of
voting rights
(including treasury shares)*
September 30, 2026
1,207,773,393
1,336,107,060
1,343,274,122

* Pursuant to Article 223-11 of the Règlement général de l’Autorité des Marchés Financiers.

This information is also available on the internet website of sanofi:

https://www.sanofi.com/en/investors/sanofi-share-and-adrs/shares-structure-vote


Investor Relations Department
e-mail: investor.relations@sanofi.com

Attachment


Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.